Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
Wolpin, B. M., O'Reilly, E. M., Ko, Y. J., Blaszkowsky, L. S., Rarick, M., Rocha-Lima, C. M., Ritch, P., Chan, E., Spratlin, J., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L., HaVolume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt066
Date:
July, 2013
File:
PDF, 239 KB
english, 2013